2-169277681-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004525.3(LRP2):​c.1772+64C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.775 in 1,405,144 control chromosomes in the GnomAD database, including 423,772 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.77 ( 45681 hom., cov: 32)
Exomes 𝑓: 0.77 ( 378091 hom. )

Consequence

LRP2
NM_004525.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.518

Publications

10 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-169277681-G-C is Benign according to our data. Variant chr2-169277681-G-C is described in ClinVar as Benign. ClinVar VariationId is 1295179.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.893 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP2NM_004525.3 linkc.1772+64C>G intron_variant Intron 13 of 78 ENST00000649046.1 NP_004516.2 P98164Q7Z5C0Q7Z5C1
LRP2XM_011511183.4 linkc.1772+64C>G intron_variant Intron 13 of 77 XP_011509485.1
LRP2XM_047444340.1 linkc.848+64C>G intron_variant Intron 13 of 78 XP_047300296.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP2ENST00000649046.1 linkc.1772+64C>G intron_variant Intron 13 of 78 NM_004525.3 ENSP00000496870.1 P98164
LRP2ENST00000443831.1 linkc.1565+1691C>G intron_variant Intron 12 of 22 2 ENSP00000409813.1 E9PC35

Frequencies

GnomAD3 genomes
AF:
0.774
AC:
117620
AN:
151982
Hom.:
45641
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.742
Gnomad AMI
AF:
0.800
Gnomad AMR
AF:
0.795
Gnomad ASJ
AF:
0.824
Gnomad EAS
AF:
0.915
Gnomad SAS
AF:
0.607
Gnomad FIN
AF:
0.806
Gnomad MID
AF:
0.839
Gnomad NFE
AF:
0.781
Gnomad OTH
AF:
0.803
GnomAD4 exome
AF:
0.775
AC:
970618
AN:
1253042
Hom.:
378091
AF XY:
0.769
AC XY:
487316
AN XY:
633902
show subpopulations
African (AFR)
AF:
0.745
AC:
21655
AN:
29060
American (AMR)
AF:
0.797
AC:
34718
AN:
43584
Ashkenazi Jewish (ASJ)
AF:
0.825
AC:
20470
AN:
24818
East Asian (EAS)
AF:
0.899
AC:
34483
AN:
38350
South Asian (SAS)
AF:
0.606
AC:
49115
AN:
81088
European-Finnish (FIN)
AF:
0.808
AC:
42870
AN:
53064
Middle Eastern (MID)
AF:
0.816
AC:
4378
AN:
5366
European-Non Finnish (NFE)
AF:
0.781
AC:
721466
AN:
924314
Other (OTH)
AF:
0.776
AC:
41463
AN:
53398
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
11238
22476
33713
44951
56189
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15946
31892
47838
63784
79730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.774
AC:
117717
AN:
152102
Hom.:
45681
Cov.:
32
AF XY:
0.773
AC XY:
57450
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.742
AC:
30776
AN:
41466
American (AMR)
AF:
0.795
AC:
12145
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.824
AC:
2859
AN:
3470
East Asian (EAS)
AF:
0.915
AC:
4738
AN:
5178
South Asian (SAS)
AF:
0.606
AC:
2923
AN:
4820
European-Finnish (FIN)
AF:
0.806
AC:
8529
AN:
10588
Middle Eastern (MID)
AF:
0.837
AC:
246
AN:
294
European-Non Finnish (NFE)
AF:
0.781
AC:
53088
AN:
67988
Other (OTH)
AF:
0.799
AC:
1683
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1382
2764
4147
5529
6911
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.777
Hom.:
5725
Bravo
AF:
0.778
Asia WGS
AF:
0.738
AC:
2569
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.2
DANN
Benign
0.47
PhyloP100
-0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs831003; hg19: chr2-170134191; API